phone icon(716) 674-6030 fax icon(716) 674-6052
bill pay iconPay Your Bill
Receive our Health e-Newsletter
  Home  
  Our Team  
  Patient Info  
  Services  
   
  Patient Info  

News for Healthier Living

First-Ever Clinical Trial Demonstrates Safety, Molecular Readout and Promise of Pre- and Post-Surgery Immunotherapy Combination for Patients with Operable Mesothelioma

A novel treatment approach using combination immunotherapy before and after surgery shows promise for patients with operable mesothelioma, according to a new study led by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.

September 8, 2025


September 8 2025

September 7 2025

September 6 2025

September 5 2025

September 4 2025

September 3 2025

September 2 2025

September 1 2025

August 31 2025

August 30 2025

August 29 2025

August 28 2025

August 27 2025

August 26 2025